Document Type
Fact Sheet
Publication Date
10-1-2024
Abstract
Leveraging our experience developing the monthly dapivirine vaginal ring (DVR or "PrEP ring"), which received a positive opinion from the European Medicines Agency (EMA) in 2020 for women’s HIV risk reduction, the Population Council has developed a 3-month DVR as a line-extension of the monthly DVR, with plans to submit for EMA review in the near future. The 3-month DVR is expected to significantly reduce the annual costs of HIV prevention.
Recommended Citation
IPM South Africa. 2024. "3-Month Dapivirine Vaginal Ring: A longer-acting dapivirine vaginal ring for HIV protection," factsheet. Population Council.
Language
English
Project
The Dapivirine Vaginal Ring for HIV Prevention
COinS